SCHEMBL7202747

SCHEMBL7202747

O=C(C#Cc1cccs1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.49
NTSR1 P30989 1/20 0.49
HPGDS O60760 1/20 0.46
RAB9A P51151 3/20 0.45
VCP P55072 1/20 0.45
FFAR1 O14842 1/20 0.44
MAPT P10636 5/20 0.41
ALDH1A1 P00352 4/20 0.41
NPSR1 Q6W5P4 3/20 0.41
OPRK1 P41145 2/20 0.41
HTT P42858 2/20 0.41
S1PR2 O95136 1/20 0.41
KMT2A Q03164 6/20 0.41
MEN1 O00255 5/20 0.41
HPGD P15428 3/20 0.41
NPC1 O15118 2/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7205479 0.90 VCP (0.44) HSP90AA1NTSR1HPGDSRAB9AVCP
SCHEMBL7200606 0.86 APP (0.49) HSP90AA1NTSR1RAB9AVCPFFAR1
SCHEMBL7204230 0.85 APP (0.47) RAB9AVCPFFAR1MAPTALDH1A1
SCHEMBL7203523 0.85 RAB9A (0.49) RAB9AVCPFFAR1MAPTALDH1A1
SCHEMBL7204585 0.85 APP (0.51) HSP90AA1NTSR1RAB9AVCPFFAR1
SCHEMBL7203532 0.85 MAPT (0.44) HSP90AA1NTSR1VCPFFAR1MAPT
SCHEMBL7201310 0.85 VCP (0.57) RAB9AVCPFFAR1MAPTALDH1A1
SCHEMBL7200317 0.82 CES2 (0.44) RAB9AFFAR1GRM5CES1
SCHEMBL7203118 0.81 KCNK3 (0.45) RAB9AMAPTALDH1A1KMT2AMEN1
SCHEMBL7200878 0.81 APP (0.54) RAB9AMAPTALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0476645-B1 Calcium uptake inhibitors MERRELL DOW PHARMA (US) 1995-09-06 EP claimed
EP-0476645-A1 Calcium uptake inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-25 EP claimed
US-6605730-B2 3-(2-Thienyl)-5-phenyl-1H-pyrazole compounds of given formula NIHON BAYER AGROCHEM K.K. (JP) 2003-08-12 US disclosed
US-20030028034-A1 Nematicidal pyrazoles WADA KATSUAKI (JP) 2003-02-06 US disclosed
US-6310049-B1 3-(2-THIENYL),5-(SUBSTITUTED PHENYL)-1H-PYRAZOLES AND 3-(SUBSTITUTED PHENYL),5-(2-THIENYL)-1H-PYRAZOLES OF GIVEN FORMULA; ANTHELMINTICS NIHON BAYER AGROCHEM K.K. (JP) 2001-10-30 US disclosed
EP-1104418-A2 NEMATICIDAL PYRAZOLES NIHON BAYER AGROCHEM K.K. (JP) 2001-06-06 EP disclosed
WO-2000009500-A2 NEMATICIDAL PYRAZOLES NIHON BAYER AGROCHEM K.K. (JP) 2000-02-24 WO disclosed
EP-0476645-B1 Calcium uptake inhibitors MERRELL DOW PHARMA (US) 1995-09-06 EP disclosed
US-5409942-A Administering 1-phenyl-3-aryl-2-propyne-1-ones compounds MERRELL DOW PHARMACEUTICALS INC. (US) 1995-04-25 US disclosed
US-5223518-A Controlling intake in leukocytes and platelets MERRELL DOW PHARMACEUTICALS INC. (US) 1993-06-29 US disclosed
EP-0476645-A1 Calcium uptake inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030028034-A1 Nematicidal pyrazoles CBR3, CBR1, CCR4 HSP90AA1 631/4885NTSR1 1507/4885HPGDS 2920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.